IVI Madrid
Quick facts
Marketed products
- Biosimilar recombinant FSH · Reproductive Medicine / Fertility
Biosimilar recombinant FSH stimulates the growth and maturation of ovarian follicles by binding to and activating follicle-stimulating hormone receptors on granulosa cells. - human menopausal gonadotropin · Reproductive Medicine / Fertility
Human menopausal gonadotropin (hMG) is a hormone preparation containing follicle-stimulating hormone (FSH) and luteinizing hormone (LH) that stimulates ovarian follicle development and maturation in women undergoing fertility treatment. - Levonorgestrel and ethinylestradiol · Contraception / Reproductive Health
Levonorgestrel and ethinylestradiol is a combined oral contraceptive that prevents ovulation by suppressing gonadotropin hormones and altering cervical mucus and endometrial conditions. - triptorelin, recombinant LH · Reproductive Medicine / Fertility
Triptorelin is a GnRH agonist that stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to support reproductive function. - Urinary FSH · Reproductive Medicine / Fertility
Urinary FSH is a purified preparation of follicle-stimulating hormone extracted from human urine that stimulates follicle development and estrogen production in women undergoing fertility treatment.
Phase 3 pipeline
- Administration of letrozole · Oncology
Letrozole is an aromatase inhibitor that blocks the conversion of androgens to estrogen, reducing circulating estrogen levels in postmenopausal women.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about IVI Madrid
What are IVI Madrid's marketed drugs?
Top marketed products include Biosimilar recombinant FSH, human menopausal gonadotropin, Levonorgestrel and ethinylestradiol, triptorelin, recombinant LH, Urinary FSH.
What is IVI Madrid's pipeline?
IVI Madrid has 1 drugs in Phase 3, 1 in Phase 2, 1 in Phase 1. Late-stage candidates include Administration of letrozole.
Related
- Biosimilar recombinant FSH · Reproductive Medicine / Fertility
- human menopausal gonadotropin · Reproductive Medicine / Fertility
- Levonorgestrel and ethinylestradiol · Contraception / Reproductive Health
- triptorelin, recombinant LH · Reproductive Medicine / Fertility
- Urinary FSH · Reproductive Medicine / Fertility
- Sector hub: All tracked pharma companies